Probiotics for inflammatory bowel disease

Hideko Iizuka, Hiromasa Takaishi, Toshifumi Hibi

Research output: Contribution to journalArticle

Abstract

Probiotics are defined as live microorganisms that may beneficially affect the host by improving the balance of the intestinal micro flora. In spontaneous animal models of inflammatory bowel disease (IBD), the influence of the enteric flora on gut inflammatory activity has been demonstrated, as germ free animals do not develop disease. Modification of the activity of the intestinal flora using probiotics has been investigated as a way of controlling IBD. However, there is still considerable work to be done before probiotics can be considered as part of the standard treatment of IBD. Probiotic cocktails should be carefully studied and the individual bacterial constituents evaluated in clinical settings. Several studies are currently underway to assess these issues. Further study of placebo controlled trial testing therapeutic role of probiotic bacteria in human trials is warranted.

Original languageEnglish
Pages (from-to)776-780
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Volume63
Issue number5
Publication statusPublished - 2005

Fingerprint

Probiotics
Inflammatory Bowel Diseases
Animal Models
Placebos
Bacteria
Therapeutics
Gastrointestinal Microbiome

Cite this

Probiotics for inflammatory bowel disease. / Iizuka, Hideko; Takaishi, Hiromasa; Hibi, Toshifumi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 63, No. 5, 2005, p. 776-780.

Research output: Contribution to journalArticle

Iizuka, Hideko ; Takaishi, Hiromasa ; Hibi, Toshifumi. / Probiotics for inflammatory bowel disease. In: Nippon rinsho. Japanese journal of clinical medicine. 2005 ; Vol. 63, No. 5. pp. 776-780.
@article{67aa38160b6844968cc13bff3dd930d4,
title = "Probiotics for inflammatory bowel disease",
abstract = "Probiotics are defined as live microorganisms that may beneficially affect the host by improving the balance of the intestinal micro flora. In spontaneous animal models of inflammatory bowel disease (IBD), the influence of the enteric flora on gut inflammatory activity has been demonstrated, as germ free animals do not develop disease. Modification of the activity of the intestinal flora using probiotics has been investigated as a way of controlling IBD. However, there is still considerable work to be done before probiotics can be considered as part of the standard treatment of IBD. Probiotic cocktails should be carefully studied and the individual bacterial constituents evaluated in clinical settings. Several studies are currently underway to assess these issues. Further study of placebo controlled trial testing therapeutic role of probiotic bacteria in human trials is warranted.",
author = "Hideko Iizuka and Hiromasa Takaishi and Toshifumi Hibi",
year = "2005",
language = "English",
volume = "63",
pages = "776--780",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "5",

}

TY - JOUR

T1 - Probiotics for inflammatory bowel disease

AU - Iizuka, Hideko

AU - Takaishi, Hiromasa

AU - Hibi, Toshifumi

PY - 2005

Y1 - 2005

N2 - Probiotics are defined as live microorganisms that may beneficially affect the host by improving the balance of the intestinal micro flora. In spontaneous animal models of inflammatory bowel disease (IBD), the influence of the enteric flora on gut inflammatory activity has been demonstrated, as germ free animals do not develop disease. Modification of the activity of the intestinal flora using probiotics has been investigated as a way of controlling IBD. However, there is still considerable work to be done before probiotics can be considered as part of the standard treatment of IBD. Probiotic cocktails should be carefully studied and the individual bacterial constituents evaluated in clinical settings. Several studies are currently underway to assess these issues. Further study of placebo controlled trial testing therapeutic role of probiotic bacteria in human trials is warranted.

AB - Probiotics are defined as live microorganisms that may beneficially affect the host by improving the balance of the intestinal micro flora. In spontaneous animal models of inflammatory bowel disease (IBD), the influence of the enteric flora on gut inflammatory activity has been demonstrated, as germ free animals do not develop disease. Modification of the activity of the intestinal flora using probiotics has been investigated as a way of controlling IBD. However, there is still considerable work to be done before probiotics can be considered as part of the standard treatment of IBD. Probiotic cocktails should be carefully studied and the individual bacterial constituents evaluated in clinical settings. Several studies are currently underway to assess these issues. Further study of placebo controlled trial testing therapeutic role of probiotic bacteria in human trials is warranted.

UR - http://www.scopus.com/inward/record.url?scp=20644436048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20644436048&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 776

EP - 780

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 5

ER -